Navigation Links
China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results
Date:5/2/2008

2,625,216

Intangible assets, net of accumulated

amortization of $291,809 and $221,715,

respectively 2,515,356 2,063,252

Advances for purchase of intangible

assets 2,801,633 807,345

Deferred tax assets 195,303 187,509

Total Non-current Assets 8,148,322 5,683,322

TOTAL ASSETS $50,490,383 $43,706,320

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:

Trade accounts payable $590,722 $297,299

Accrued expenses 265,008 261,301

Accrued taxes payable 1,078,850 311,009

Other payables 42,521 86,161

Advances from customers 359,646 261,583

Short-term notes payable 2,420,894 2,693,428

Total Current Liabilities 4,757,641 3,910,781

Research and development commitments 35,601 34,181

Total Liabilities 4,793,242 3,944,962

Stockholders' Equity:

Common stock, $0.001 par value,

60,000,000 shares authorized,

37,278,938 shares issued and

outstanding 37,279 37,279

Additional paid-in capital 11,678,606 11,678,606

Foreign currency translation adjustment 4,584,546 2,839,304

Retained earnings 29,396,710 25,206,169

Total Stockholders' Equity 45,697,141 39,761,358

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $50,490,383 $43,706,320

CHI
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. DuPont Partnering with China to Increase Farm Productivity
3. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
4. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
9. China Bio Energy Reports Fiscal 2007 Financial Results
10. Transgenomic Opens Pharmacogenomics Laboratory in China
11. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... operation up to 1500 bar. The sanitary design gauge of the NS2006L is ... , The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: ... committed to progressing its ground-breaking technology platforms to Phase ... ensure the Company delivers the best value for shareholders. ... , said the Company currently had an extensive program ... programs and academic partnerships and initiatives, and he was ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... Inc.,(OTC Bulletin Board: AVNA), announced today that its ... from SELEX GALILEO,totaling $629,000. SELEX GALILEO, a Finmeccanica ... organizations, is a leader in,surveillance, protection, tracking, targeting, ... the third order in 18 months from,SELEX GALILEO. ...
... CHAGRIN FALLS, Ohio, June 24 Knowledge Enterprises,Inc. ... the 4th Annual Orthopaedic Manufacturing & Technology Exposition ... 2007, with total attendance,nearing 1,000. "Based on the ... honored to report that OMTEC has secured a ...
... of Proven Clinical Trial Capability into the Frontage ... ... June 24 Frontage Laboratories,( http://www.frontagelab.com ) (Malvern and Exton, ... of bioanalytical, pre-clinical and,drug development services to the pharmaceutical industry, ...
Cached Biology Technology:Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 2Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 3Advance Nanotech's Owlstone Subsidiary Receives a $629,000 Order From Selex Galileo 4OMTEC 2008 Boasts Record Attendance and Secures Premier Position as Must-attend for Orthopaedic Companies 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 4
(Date:7/7/2015)... , July 7, 2015  Based on ... Frost & Sullivan recognizes Credence ID, LLC with ... Entrepreneurial Company of the Year Award. Credence ID ... aid in its mission of offering enrollment and ... globally. As Credence ID was formed by experts ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint Cards ... FPC1035, FPC1145 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... sensors will be used by smartphone manufacturers in ... included in the communicated revenue guidance of approximately 2,200 MSEK ...
(Date:6/26/2015)... SPRINGVILLE, Utah , June 26, 2015 ATL ... assemblies and devices with specialties in single use solutions, headquartered ... acquisition of MedConx, Inc. (a California ... , and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... compact microscope invented at Rice University is proving its ... published online today in the journal PLoS ONE ... his portable, battery-operated fluorescence microscope, which costs $240, stacks ... as $40,000 in diagnosing signs of tuberculosis. Miller ...
... University of Washington two years ago launched an ambitious project ... The game, Foldit, turns one of the hardest problems in ... Thousands of people have now played a game that asks ... or rescue a princess. Results published Thursday (Aug. 5) ...
... vast 1.5 million acres of mangrove swamps, sawgrass prairies ... of grass--be affected by the Gulf oil spill? ... entered the Loop Current or reached the Everglades, this ... study the effects of the spill on seagrasses and ...
Cached Biology News:Compact microscope a marvel 2Compact microscope a marvel 3Gaming for a cure: Computer gamers tackle protein folding 2Gaming for a cure: Computer gamers tackle protein folding 3Gaming for a cure: Computer gamers tackle protein folding 4Gulf oil spill: NSF funds research on impacts to Florida Everglades 2
Standard 2" or 3" Plastic can be ordered with 81 or 100 cell dividers. Mini 2" Plastics Boxes come standard with 25 cell dividers. Plastic boxes can also be ordered with corresponding freezer racks...
Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...
Request Info...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Biology Products: